MabCure aims to research novel cancer diagnostics and treatments by identifying markers and antigens specific to tumors. I do not possess the medical expertise to ascertain whether this is a valid approach. I can only wonder how a traditional laboratory approach like this will fare when faced with massively distributed competition from small-scale biohacking labs. There is probably enough information in the public domain for a networked collaborative of garage biolabs to assemble bio-widgets that can identify markers.
I'd rather participate in a local biospace than invest in a biotech company doing marker identification the old-fashioned way.
Full disclosure: No position in MBCI at this time.